Autres langues Alimera Sciences, Inc.

Actions

ALIM

US0162592028

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 13/09/2024			Varia. 5j.	Varia. 1 janv.
5,540 ^USD	-0,18%		-.--%	-

16/09/24	ANI Pharmaceuticals finalise l'achat d'Alimera Sciences, prévoit des bénéfices 'substantiellement plus élevés' après l'opération	MT
16/09/24	ANI Pharmaceuticals, Inc. (NasdaqGM:ANIP) a conclu l'acquisition d'Alimera Sciences, Inc. (NasdaqGM:ALIM) auprès de Caligan Partners Master Fund LP et Caligan Partners Master Fund LP, gérés par Caligan Partners, LP et d'autres.	CI

Autres langues

16/09/24	ANI Pharmaceuticals Completes Purchase of Alimera Sciences, Sees 'Substantially Higher' Earnings After Deal
16/09/24	ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
16/09/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) dropped from NASDAQ Composite Index
16/09/24	ANI Pharmaceuticals, Inc. completed the acquisition of Alimera Sciences, Inc. from Caligan Partners Master Fund LP and Caligan Partners Master Fund LP, managed by Caligan Partners, LP and others.
11/09/24	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday as Looming CPI Data Likely to Provide Rate-Cut Clues
11/09/24	ANI Pharmaceuticals, Alimera Sciences to Close Merger Next Week
11/09/24	ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
11/09/24	ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
10/09/24	Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close
10/09/24	ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
10/09/24	Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
10/09/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) dropped from S&P TMI Index
20/08/24	ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM
06/08/24	Alimera Sciences: Q2 Earnings Snapshot
06/08/24	Alimera Sciences Reports Second Quarter 2024 Results
06/08/24	Alimera Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
17/07/24	Processa Pharmaceuticals Appoints Russell Skibsted as CFO
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell Small Cap Comp Value Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell Small Cap Completeness Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell 2000 Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell 3000E Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell 3000 Growth Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell Microcap Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell 2500 Value Index
01/07/24	Alimera Sciences, Inc.(NasdaqGM:ALIM) added to Russell Microcap Growth Index